OCOnder Colakoğlu

Onder Colakoğlu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Onder Colakoğlu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Gül Colakoğlu

    2 shared publications
  • A. Kupelioglu

    Gastroenterology Clinics, Ataturk Training and Research Hospital,1 Gastroenterology Clinics,2 Pathology Clinics,3 Dokuz Eylul University Medical School, Izmir, Turkey

    1 shared publication
  • B. Unsal

    Gastroenterology Clinics, Ataturk Training and Research Hospital,1 Gastroenterology Clinics,2 Pathology Clinics,3 Dokuz Eylul University Medical School, Izmir, Turkey

    1 shared publication
  • Belkis Unsal

    1 shared publication
  • Bengür Taşkiran

    1 shared publication
  • E. Tankurt

    Gastroenterology Clinics, Ataturk Training and Research Hospital,1 Gastroenterology Clinics,2 Pathology Clinics,3 Dokuz Eylul University Medical School, Izmir, Turkey

    1 shared publication

Latest Publications

    • 1 December 2007
      • Vol. 18  (4) , 245-9

    Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis.

    by Onder Colakoğlu, Bengür Taşkiran, Gül Colakoğlu, Servet Kizildağ, Fulya Ari Ozcan, Belkis Unsal

    Impaired growth hormone-insulin like growth factor system in hepatic cirrhosis leads to cirrhosis-related complications. In this study, we aimed to investigate whether serum levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 are related to the level of hepatic dysfunction, clinical grade, and etiologic factors of the disease in patients with liver cirrhosis. Forty-two patients with liver cirrhosis who were diagnosed by means of clinical findings, endoscopy, imaging studies, or histopathology were enrolled in the study. An age- and sex-matched control group was comprised of 37 healthy controls with no signs of liver disease by clinical or laboratory findings. The demographic features (age, sex, height, and weight) and serum levels of liver function tests, urea, creatinine, sodium, potassium, insulin like growth factor-1, and insulin like growth factor binding protein- 3 and hemogram values were recorded for each individual. The patients were grouped according to Child Pugh classification and etiology. Insulin like growth factor-1 and insulin like growth factor binding protein-3 levels were significantly lower in the cirrhotic group in comparison to the control group (p<0.005). A statistically significant decrease in levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 was correlated with the degree of liver dysfunction, namely, lowest decrease in Child Pugh class A and highest decrease in class C. With respect to etiology, insulin like growth factor- 1 levels of alcohol-related liver cirrhosis were significantly lower than those of hepatitis B- related cirrhosis. There was no relation between insulin like growth factor binding protein-3 level and etiology. In the cirrhotic group, insulin like growth factor- 1 level was positively correlated with serum albumin and negatively correlated with serum creatinine and sodium levels and spleen size. Likewise, insulin like growth factor binding protein-3 level was positively correlated with serum albumin. There was a negative correlation between insulin like growth factor binding protein-3 level and serum bilirubin and spleen size. Insulin like growth factor-1 and insulin like growth factor binding protein-3 levels are related to the level of clinical impairment and were independent of the etiology. They may serve as novel markers of hepatocellular dysfunction.


  • Toxic hepatitis associated with paroxetine

    by O. Colakoglu, E. Tankurt, B. Unsal, F. Ugur, A. Kupelioglu, Z. Buyrac, Z. Akpinar

    Hepatotoxicity is a rare complication of paroxetine, a selective serotonin reuptake inhibitor. Regarded as safe in therapeutic use, there have been reports of cases of severe hepatic dysfunction with gross elevations of transaminase levels that may be related to this drug. We report here severe adverse cholestatic and hepatocellular injury in a patient taking paroxetine probably due to an immune-mediated hypersensitivity reaction.


    • 1 June 2005
      • Vol. 16  (2) , 114-6

    Morgagni hernia in an adult: atypical presentation and diagnostic difficulties.

    by Onder Colakoğlu, Mehmet Haciyanli, Müjde Soytürk, Gül Colakoğlu, Ilkay Simşek

    Foramen of Morgagni hernias are rare diaphragmatic hernias, usually occurring on the right and located in the anterior mediastinum. Adult patients diagnosed with a foramen of Morgagni hernia are usually asymptomatic and associated with obesity, trauma or other causes of increased intraabdominal pressure. Plain pulmonary roentgenogram, radiological studies of the gastrointestinal system with contrast material, computerized tomography and magnetic resonance imaging studies are helpful in diagnosis. In this article, a 78-year-old female case with a Morgagni hernia incidentally diagnosed on chest X-ray is presented.